- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03019952
Effectiveness of the Care Coordination, Assessment, and Responsive Engagement Program for Transition-aged Adolescents (t-CARE) With ASD (t-CARE)
March 11, 2019 updated by: Michael Murray, Milton S. Hershey Medical Center
An analysis of data for adolescents and young adults diagnosed with Autism Spectrum Disorders (ASDs) who are evaluated as part of the Care Coordination, Assessment, and Responsive Engagement for transition-aged adolescents (t-CARE) program which replaced the former Autism Life Care Model (ALCM), which was a clinical program implemented between Fall 2014 and April 2016.
The individuals enrolled in the program will be administered a standardized assessment battery during each visit with the care coordinator or study coordinator.
The proposed study will analyze data gathered during each of the assessment periods in order to check the efficacy and viability of the protocol.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Current collaboration between individuals, families, and providers through in-person meetings are extremely infrequent, costly, and occur most often when providers are intimately involved as part of a multidisciplinary team in a single setting such as at a school.
Often, little information is transmitted between providers and/or school personnel in determining treatment goals and interventions.
Furthermore, the transmission of information is often provider to provider or school personnel to provider, which excludes direct patient-input and lessens transparency in decision making.
In an effort to improve current care and therefore improve successful adult transitions for adolescents with ASD, t-CARE is designed to mimic multidisciplinary team meetings.
These meetings are incredibly impactful as they include direct individual and family involvement through facilitated information-sharing, while also maintaining patient-centered care across multiple providers and complex systems of care.
Study Type
Interventional
Enrollment (Actual)
52
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Pennsylvania
-
Hershey, Pennsylvania, United States, 17033
- The Penn State College of Medicine
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years to 19 years (Child, Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Between 14 and 19 years of age upon entry into t-CARE
- A primary diagnosis of Asperger's Syndrome or autism, as indicated by the Social Responsiveness Scale, Second Edition (SRS-2; Constantino & Gruber, 2012)
- English as primary language spoken
- Ability to self-report (i.e. understand and answer assessment questions written at a third grade comprehension level) (self-report questions to be asked by study coordinator)
Exclusion Criteria:
- A significant language delay
- Significant psychosis as indicated through a semi-structured interview (Mini-International Neuropsychiatric Interview)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Holmes and Rahe Stress Scale
Time Frame: annually over 2 years
|
annually over 2 years
|
SRS-2
Time Frame: annually over 2 years
|
annually over 2 years
|
Waisman Activities of Daily Living Scale
Time Frame: annually over 2 years
|
annually over 2 years
|
Intolerance of Uncertainty
Time Frame: annually over 2 years
|
annually over 2 years
|
PROMIS Multi-Domain 49
Time Frame: monthly over 2 years
|
monthly over 2 years
|
Temple University Community Participation (TUCP) measure
Time Frame: quarterly over 2 years
|
quarterly over 2 years
|
PROMIS proxy measures
Time Frame: quarterly over 2 years
|
quarterly over 2 years
|
PROMIS SF measures
Time Frame: monthly over 2 years
|
monthly over 2 years
|
Self-Determination Scale
Time Frame: annually over 2 years
|
annually over 2 years
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Closure Survey
Time Frame: after completion of 2 year study
|
after completion of 2 year study
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Michael J. Murray, M.D., Hershey Medical Center
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2016
Primary Completion (Actual)
April 9, 2018
Study Completion (Actual)
April 9, 2018
Study Registration Dates
First Submitted
January 11, 2017
First Submitted That Met QC Criteria
January 11, 2017
First Posted (Estimate)
January 13, 2017
Study Record Updates
Last Update Posted (Actual)
March 13, 2019
Last Update Submitted That Met QC Criteria
March 11, 2019
Last Verified
March 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- STUDY00003849
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Autism Spectrum Disorder
-
Stanford UniversityCalifornia Department of Developmental ServicesRecruitingAutism Spectrum Disorder | Autistic Disorder | Autism | Autism Spectrum Disorders | Autistic Disorders Spectrum | Autistic Spectrum Disorder | Autistic Spectrum DisordersUnited States
-
Hoffmann-La RocheCompletedAutism Spectrum Disorder (ASD)United States, Canada, Italy, Spain
-
Axial Therapeutics, Inc.Active, not recruitingAutism Spectrum Disorder (ASD)United States, Australia, New Zealand
-
Technion, Israel Institute of TechnologyCompleted
-
Stanford UniversityNational Institute on Deafness and Other Communication Disorders (NIDCD)CompletedAutism | Autism Spectrum Disorder (ASD)United States
-
Corporacion Parc TauliUnknown
-
Institut de Recherches Internationales ServierADIR, a Servier Group companyTerminatedAutism Spectrum Disorder (ASD)Spain, United States, Hungary, Poland, Australia, United Kingdom, Brazil, Czechia, France, Italy, Portugal, Slovakia
-
Centre Hospitalier Intercommunal Robert BallangerRecruitingAutism Spectrum Disorder (ASD)France
-
Florida Gulf Coast UniversityCompletedAutism Spectrum Disorder High-FunctioningUnited States
-
Hospital Universitario Dr. Jose E. GonzalezUnknownAutism | Autism SpectrumMexico
Clinical Trials on Care Coordination Visit
-
VA Office of Research and DevelopmentCompletedSmokingUnited States
-
Johns Hopkins UniversityNational Institute of Mental Health (NIMH); National Institute on Aging (NIA); Leonard & Helen R. Stulman Charitable Foundation and other collaboratorsCompleted
-
Arizona State UniversityNational Institute of Nursing Research (NINR); University of Wisconsin, MilwaukeeCompletedCognitive Impairment | Chronic IllnessUnited States
-
University Hospital, BordeauxCompletedCare Coordination in OncologyFrance
-
Mathematica Policy Research, Inc.Centers for Medicare and Medicaid ServicesUnknownCoronary Artery Disease | Diabetes | Cancer | Chronic Obstructive Pulmonary Disease | Major Depression | Alzheimer's Disease | Congestive Heart Failure | Cerebrovascular Disease | Psychotic DisorderUnited States
-
SeaCare Health ServicesNew Hampshire Charitable FoundationTerminatedType 2 DiabetesUnited States
-
HealthPartners InstitutePatient-Centered Outcomes Research Institute; Minnesota Department of Health; MN Community MeasurementCompletedChronic Disease | Multi-morbidity | Care CoordinationUnited States
-
University of Texas Southwestern Medical CenterCompletedBreast Cancer | Colorectal CancerUnited States
-
University of Texas at AustinCompletedHIV | Substance Use | Care CoordinationUnited States
-
University of Wisconsin, MadisonActive, not recruitingEmergency Department VisitUnited States